Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
398.4500 5.20 (1.32%)
NSE Nov 26, 2025 15:31 PM
Volume: 1.6M
 

logo
Biocon Ltd.
17 Sep 2021
398.45
1.32%
Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
livemint
Biocon Biologics Limited, a subsidiary of Biocon, on Thursday announced a strategic alliance with Serum Institute Life Sciences, a subsidiary of SII
Biocon Ltd. has an average target of 390.50 from 4 brokers.
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
NDTV Profit | 17 Sep 2021 4 more
More from Biocon Ltd.
Recommended
Market closes higher, buoyed by lower oil prices and anticipation of Fed rate cut
Trendlyne Marketwatch | 26 Nov 2025, 04:04PM
Five stocks to buy from analysts this week - November 26, 2025
The Baseline | 26 Nov 2025, 11:57AM
A long drawn out R&D plan may be finally paying off for Biocon
| 20 Aug 2020